Search News

Corporate Industry Technology Medical Updates

Ventricular Assist Device

Industry
Dr. Po-Lin Hsu and her "Heart" of magAssist 2020-05-10
Technology
magAssist's extracorporeal artificial heart product made the first public appearance at an international academic conference 2019-11-28
Medical Updates
Zhujiang Hospital Transitions from ECMO + IABP to MoyoAssist® in the Management of Cardiogenic Shock 2025-04-30
Medical Updates
Rapid Postoperative Recovery Achieved with MoyoAssist® in High-Risk Cardiac Surgery 2025-04-12
Medical Updates
High-Risk Coronary Revascularization Supported by MoyoAssist® Magnetic Levitation 2025-04-02
Corporate
TCT 2024 | NyokAssist® Makes Global Debut as a Novel Interventional Ventricular Assist Device 2024-11-01
Corporate
magAssist Presents MoyoAssist® at ESAO 2024, Advancing Global Dialogue in Artificial Organ Technology 2024-09-26
Corporate
First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi 2023-08-23
Corporate
magAssist's NyokAssist™ granted Designation by the FDA as a Breakthrough Device 2023-08-17
Corporate
FDA Grants "Breakthrough Device" Designation to magAssist's NyokAssist® Interventional Ventricular Assist Device 2023-08-17

Tabs： percutaneous ventricular assist device, myocardial infarction, maglev artificial heart technology, end-stage respiratory failures, VA-ECMO, ESA, the application of MoyoAssist, portable ECMO, severe shortage of heart donors, Potential Unicorn,